Bull’s Eye Report: MetLife (MET)

Buy MET at current levels

   

At StateoftheMarkets.com, we strive to “own the best and ignore the rest” in our equity portfolios. Toward this end, each day we search our database for a “top stock” (a top rated company in terms of earnings strength as well as company and industry performance) that presents a strong technical “set up” and a good entry point.

In short, when our equity team is looking to add a stock to one of our portfolios, the “bull’s eye” stock shown below is generally their first choice.

Company Symbol Industry Stock Rating YTD% Gain S.T.
Stop Loss
MetLife Inc MET Life & Health Insurance 9.2 +8.17% $37.47

Why We Like The Stock:

MetLife (NYSE:MET) is our most compelling buy today due to the fact that it is a top rated stock (in terms of earnings strength and company/industry performance). Like other insurance stocks Prudential Financial (NYSE:PRU), Principal Financial Group (NYSE:PFG), and Lincoln National Corp. (NYSE:LNC), MET features a positive technical setup that has pulled back off its recent mid-March highs. Since venturing a hair above the $40 mark, MET has sold off in the short term, and is currently basing around the $37.80 level, comfortably above its 50-day moving average. Old resistance from January and February has become new support, and should MET be able to hold this price and cross above its short-term moving averages over the next few days, all signs would point to it making a run back up to recent highs. While we would not hold the stock any lower than its 50-day moving average ($37.42), we think it is a compelling buy at current prices.

We Would Be Buyers:

At the current price (~$37.90).

Company Profile:

MetLife is a provider of insurance, annuities and employee benefit programs. Through its subsidiaries and affiliates, MetLife operates in the United States, Japan, Latin America, Asia Pacific, Europe and the Middle East. It is organized into six segments: Insurance Products, Retirement Products, Corporate Benefit Funding and Auto & Home (collectively, U.S. Business), and Japan and Other International Regions (collectively, International). In addition, the company reports certain of its results of operations in Corporate & Other, which includes MetLife Bank, National Association (MetLife Bank) and other business activities. U.S. Business provides insurance and financial services products, including life, dental, disability, auto and homeowner insurance, guaranteed interest and stable value products, and annuities through independent retail distribution channels. In January 2013, it completed the sale of MetLife Bank, N.A.’s deposit business.

Stock Rating: 9.2

The Stock Rating indicates the combined score of our proprietary Earning Strength and Company Performance models. The rating scale is 0 – 10 with 10 being the highest.

Metlife – Last Three Months

MET 1 Bull's Eye Report: MetLife (MET)

Metlife – Last 12 Months

MET 2 Bull's Eye Report: MetLife (MET)

Metlife – Last Five Years

MET 3 Bull's Eye Report: MetLife (MET)
Looking to trade the Bull’s Eye stock picks? Click here to download our free Special Report, “How We Identify Our “Bull’s Eye” Picks & How You Can Profit Trading Them”
At the time of publication the editor and affiliated companies own the following positions: None

Note: Positions may be bought or sold while this publication is in circulation without notice.


Article printed from InvestorPlace Media, http://investorplace.com/247trader/bulls-eye-report-metlife-met/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.